NoNO Revenue and Competitors
Estimated Revenue & Valuation
- NoNO's estimated annual revenue is currently $13.5M per year.
- NoNO's estimated revenue per employee is $155,000
Employee Data
- NoNO has 87 Employees.
- NoNO grew their employee count by 30% last year.
NoNO's People
Name | Title | Email/Phone |
---|---|---|
1 | President and CEO | Reveal Email/Phone |
2 | Chief Business Officer | Reveal Email/Phone |
3 | Chief Regulatory and Strategy Officer (CRSO) | Reveal Email/Phone |
4 | VP Clinical Operations and Safety | Reveal Email/Phone |
5 | VP QA, Compliance and Information Technology | Reveal Email/Phone |
6 | Associate Director, QA GCP/PV | Reveal Email/Phone |
7 | Associate Director, Analytical | Reveal Email/Phone |
8 | Senior Director Project Management | Reveal Email/Phone |
9 | Associate Director, Manufacturing | Reveal Email/Phone |
10 | Drug Safety Manager | Reveal Email/Phone |
NoNO Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.7M | 9 | -72% | $39.4M | N/A |
#2 | $0.9M | 11 | -83% | $23.8M | N/A |
#3 | $87.6M | 565 | 6% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $7.8M | 50 | -68% | N/A | N/A |
#6 | $13.5M | 87 | 30% | N/A | N/A |
#7 | $17.8M | 115 | -6% | N/A | N/A |
#8 | $0.9M | 11 | -39% | N/A | N/A |
#9 | $13.6M | 88 | -20% | $86M | N/A |
#10 | $20M | 129 | -12% | N/A | N/A |
What Is NoNO?
NoNO Inc. is a clinical-stage biotherapeutics company dedicated to the research and development of pharmaceuticals for the treatment of common health disorders with unmet needs, including acute ischemic stroke.
keywords:N/AN/A
Total Funding
87
Number of Employees
$13.5M
Revenue (est)
30%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $21.1M | 87 | 2% | N/A |
#2 | $30.7M | 87 | 1% | N/A |
#3 | N/A | 87 | 21% | N/A |
#4 | $28.3M | 87 | -2% | N/A |
#5 | $28.7M | 87 | N/A | N/A |